Lead Product(s) : Pentamethylethane
Therapeutic Area : Neurology
Study Phase : Phase IV
Sponsor : GSK | Currax
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 15, 2010
Lead Product(s) : Pentamethylethane
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Sponsor : GSK | Currax
Deal Size : Inapplicable
Deal Type : Inapplicable